Vertex Pharmaceuticals Incorporated
Research & Development
11010 Torreyana Road
San Diego
California
92121
United States
Tel: 858-404-6600
Fax: 858-404-6726
Website: http://www.vrtx.com/
About Vertex Pharmaceuticals Incorporated
178 articles about Vertex Pharmaceuticals Incorporated
-
Vertex Pharmaceuticals Incorporated Announces Positive Interim Results with Telaprevir-based Therapy in Genotype 1 Chronic Hepatitis C Patients
4/24/2008
-
Vertex Pharmaceuticals Incorporated Announces Webcast of its Presentation at the Canaccord|Adams Hepatitis C Conference
4/8/2008
-
Vertex Pharmaceuticals Incorporated Announces the Date of its First Quarter 2008 Financial Results Conference Call and Webcast
4/7/2008
-
Vertex Pharmaceuticals Incorporated Announces Acceptance of Late-Breaker Abstract on Telaprevir, Investigational HCV Protease Inhibitor, for Presentation at EASL Annual Meeting
3/31/2008
-
Vertex Pharmaceuticals Incorporated Announces Positive Results for VX-770, an Oral Investigational Agent That Targets a Defective Protein Responsible for Cystic Fibrosis
3/27/2008
-
Vertex Pharmaceuticals Incorporated Announces Webcast of its Presentation at the Cowen and Company 28th Annual Health Care Conference
3/17/2008
-
Vertex Pharmaceuticals Incorporated Announces Pricing of its Concurrent Public Offerings of Common Stock and Convertible Senior Subordinated Notes
2/13/2008
-
Vertex Pharmaceuticals Incorporated Announces Webcast of its Presentation at Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference
2/1/2008
-
Vertex Pharmaceuticals Incorporated Announces the Date of its Fourth Quarter and Full Year 2007 Financial Results Conference Call and Webcast
1/29/2008
-
Vertex Pharmaceuticals Incorporated to Begin Phase 3 Development of Telaprevir, Investigational Hepatitis C Protease Inhibitor; Trial Timing Disappoints
1/24/2008
-
Vertex Pharmaceuticals Incorporated Reports Progress in Development of Investigational HCV Drug Telaprevir and Provides Business Update
1/7/2008
-
Vertex Pharmaceuticals Incorporated Announces Webcast of its Presentation at the 26th Annual JPMorgan Healthcare Conference
1/3/2008
-
Vertex Pharmaceuticals Incorporated Announces Webcasts of Its Presentations at Three Investor Conferences
11/6/2007
-
Vertex Pharmaceuticals Incorporated First Studies Demonstrating Greater than Sixty Percent Sustained Viral Response Rates with Half the Standard Treatment Duration in Genotype 1 Chronic Hepatitis C Patients
11/2/2007
-
Vertex Pharmaceuticals Incorporated Reports Third Quarter 2007 Financial Results and Provides Development Pipeline Update
10/30/2007
-
Vertex Pharmaceuticals Incorporated Announces the Date of its Third Quarter 2007 Financial Results Conference Call and Webcast
10/10/2007
-
Vertex Pharmaceuticals Incorporated Announces Publication of Abstracts for Presentation at 58th American Association for Study of Liver Diseases Meeting
10/1/2007
-
Vertex Pharmaceuticals Incorporated Announces Webcasts of its Presentations at Two Investor Conferences
9/17/2007